156 related articles for article (PubMed ID: 30755814)
1. Functional impairment of the HIPK2 small ubiquitin-like modifier (SUMO)-interacting motif in acute myeloid leukemia.
Sung KS; Kim SJ; Cho SW; Park YJ; Tae K; Choi CY
Am J Cancer Res; 2019; 9(1):94-107. PubMed ID: 30755814
[TBL] [Abstract][Full Text] [Related]
2. Role of the SUMO-interacting motif in HIPK2 targeting to the PML nuclear bodies and regulation of p53.
Sung KS; Lee YA; Kim ET; Lee SR; Ahn JH; Choi CY
Exp Cell Res; 2011 Apr; 317(7):1060-70. PubMed ID: 21192925
[TBL] [Abstract][Full Text] [Related]
3. A Tale of Usurpation and Subversion: SUMO-Dependent Integrity of Promyelocytic Leukemia Nuclear Bodies at the Crossroad of Infection and Immunity.
Patra U; Müller S
Front Cell Dev Biol; 2021; 9():696234. PubMed ID: 34513832
[TBL] [Abstract][Full Text] [Related]
4. An L2 SUMO interacting motif is important for PML localization and infection of human papillomavirus type 16.
Bund T; Spoden GA; Koynov K; Hellmann N; Boukhallouk F; Arnold P; Hinderberger D; Florin L
Cell Microbiol; 2014 Aug; 16(8):1179-200. PubMed ID: 24444361
[TBL] [Abstract][Full Text] [Related]
5. Control of nuclear HIPK2 localization and function by a SUMO interaction motif.
de la Vega L; Fröbius K; Moreno R; Calzado MA; Geng H; Schmitz ML
Biochim Biophys Acta; 2011 Feb; 1813(2):283-97. PubMed ID: 21145359
[TBL] [Abstract][Full Text] [Related]
6. Disruption of PML nuclear bodies is mediated by ORF61 SUMO-interacting motifs and required for varicella-zoster virus pathogenesis in skin.
Wang L; Oliver SL; Sommer M; Rajamani J; Reichelt M; Arvin AM
PLoS Pathog; 2011 Aug; 7(8):e1002157. PubMed ID: 21901090
[TBL] [Abstract][Full Text] [Related]
7. Mutations of the HIPK2 gene in acute myeloid leukemia and myelodysplastic syndrome impair AML1- and p53-mediated transcription.
Li XL; Arai Y; Harada H; Shima Y; Yoshida H; Rokudai S; Aikawa Y; Kimura A; Kitabayashi I
Oncogene; 2007 Nov; 26(51):7231-9. PubMed ID: 17533375
[TBL] [Abstract][Full Text] [Related]
8. SUMO5, a Novel Poly-SUMO Isoform, Regulates PML Nuclear Bodies.
Liang YC; Lee CC; Yao YL; Lai CC; Schmitz ML; Yang WM
Sci Rep; 2016 May; 6():26509. PubMed ID: 27211601
[TBL] [Abstract][Full Text] [Related]
9. SUMO interaction motifs in Sizn1 are required for promyelocytic leukemia protein nuclear body localization and for transcriptional activation.
Cho G; Lim Y; Golden JA
J Biol Chem; 2009 Jul; 284(29):19592-600. PubMed ID: 19416967
[TBL] [Abstract][Full Text] [Related]
10. Proteasome-independent disruption of PML oncogenic domains (PODs), but not covalent modification by SUMO-1, is required for human cytomegalovirus immediate-early protein IE1 to inhibit PML-mediated transcriptional repression.
Xu Y; Ahn JH; Cheng M; apRhys CM; Chiou CJ; Zong J; Matunis MJ; Hayward GS
J Virol; 2001 Nov; 75(22):10683-95. PubMed ID: 11602710
[TBL] [Abstract][Full Text] [Related]
11. The Human Cytomegalovirus IE1 Protein Antagonizes PML Nuclear Body-Mediated Intrinsic Immunity via the Inhibition of PML De Novo SUMOylation.
Schilling EM; Scherer M; Reuter N; Schweininger J; Muller YA; Stamminger T
J Virol; 2017 Feb; 91(4):. PubMed ID: 27903803
[TBL] [Abstract][Full Text] [Related]
12. C-terminal motifs in promyelocytic leukemia protein isoforms critically regulate PML nuclear body formation.
Li C; Peng Q; Wan X; Sun H; Tang J
J Cell Sci; 2017 Oct; 130(20):3496-3506. PubMed ID: 28851805
[TBL] [Abstract][Full Text] [Related]
13. Regulation of homeodomain-interacting protein kinase 2 (HIPK2) effector function through dynamic small ubiquitin-related modifier-1 (SUMO-1) modification.
Hofmann TG; Jaffray E; Stollberg N; Hay RT; Will H
J Biol Chem; 2005 Aug; 280(32):29224-32. PubMed ID: 15958389
[TBL] [Abstract][Full Text] [Related]
14. Promyelocytic leukemia nuclear body-like structures can assemble in mouse oocytes.
Udagawa O; Kato-Udagawa A; Hirano S
Biol Open; 2022 Jun; 11(6):. PubMed ID: 35579421
[TBL] [Abstract][Full Text] [Related]
15. Nucleus accumbens associated 1 is recruited within the promyelocytic leukemia nuclear body through SUMO modification.
Tatemichi Y; Shibazaki M; Yasuhira S; Kasai S; Tada H; Oikawa H; Suzuki Y; Takikawa Y; Masuda T; Maesawa C
Cancer Sci; 2015 Jul; 106(7):848-56. PubMed ID: 25891951
[TBL] [Abstract][Full Text] [Related]
16. Stabilization of PML nuclear localization by conjugation and oligomerization of SUMO-3.
Fu C; Ahmed K; Ding H; Ding X; Lan J; Yang Z; Miao Y; Zhu Y; Shi Y; Zhu J; Huang H; Yao X
Oncogene; 2005 Aug; 24(35):5401-13. PubMed ID: 15940266
[TBL] [Abstract][Full Text] [Related]
17. The Viral SUMO-Targeted Ubiquitin Ligase ICP0 is Phosphorylated and Activated by Host Kinase Chk2.
Hembram DSS; Negi H; Biswas P; Tripathi V; Bhushan L; Shet D; Kumar V; Das R
J Mol Biol; 2020 Mar; 432(7):1952-1977. PubMed ID: 32001251
[TBL] [Abstract][Full Text] [Related]
18. Modification of nuclear PML protein by SUMO-1 regulates Fas-induced apoptosis in rheumatoid arthritis synovial fibroblasts.
Meinecke I; Cinski A; Baier A; Peters MA; Dankbar B; Wille A; Drynda A; Mendoza H; Gay RE; Hay RT; Ink B; Gay S; Pap T
Proc Natl Acad Sci U S A; 2007 Mar; 104(12):5073-8. PubMed ID: 17360386
[TBL] [Abstract][Full Text] [Related]
19. Zinc controls PML nuclear body formation through regulation of a paralog specific auto-inhibition in SUMO1.
Lussier-Price M; Wahba HM; Mascle XH; Cappadocia L; Bourdeau V; Gagnon C; Igelmann S; Sakaguchi K; Ferbeyre G; Omichinski JG
Nucleic Acids Res; 2022 Aug; 50(14):8331-8348. PubMed ID: 35871297
[TBL] [Abstract][Full Text] [Related]
20. Acetylation of SUMO1 Alters Interactions with the SIMs of PML and Daxx in a Protein-Specific Manner.
Mascle XH; Gagnon C; Wahba HM; Lussier-Price M; Cappadocia L; Sakaguchi K; Omichinski JG
Structure; 2020 Feb; 28(2):157-168.e5. PubMed ID: 31879127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
